The Zhitong Finance App learned that Hong Kong stocks are currently setting off a new wave of repurchases. According to Wind statistics, in November of this year, the total number of shares repurchased by listed companies in the Hong Kong stock market exceeded 700 million shares. Entering December, the active trend of repurchases in the Hong Kong stock market continued. In just a few trading days in early December, the cumulative number of shares repurchased exceeded 300 million shares. It is worth noting that in this wave of Hong Kong stock repurchases, leading technology companies are particularly prominent in leading technology companies.
Yidu Technology (02158) is a leading AI medical company. On December 12, the company issued an announcement showing that it repurchased 155,000 shares at a price of HK$5.1 per share on the same day, with a repurchase amount of about HK$790,000. Since December, the company has repurchased 7 times, with a total repurchase of about 2.11 million shares, with a total amount exceeding HK$10.8 million.
Behind the intensive buybacks is the company's firm recognition of its own value, which also relies on the dual support of performance improvement and business expansion. Yidu Technology achieved key breakthroughs in profit quality and operational efficiency in its 2026 interim results. The current business adjusted EBITDA of about 54 million yuan, double that of the same period last year, and is close to break-even at the accounting statement level.
Everbright Securities pointed out in a follow-up report that the company has recently made many advances in implementing AI medical innovation, including deep participation in the Beijing National Artificial Intelligence Application Pilot Base in the medical field, winning the bid for Phase III clinical research projects, and adding “welfare insurance” services in Hebei and Guangzhou. According to the report, its medical model has initially constructed a closed loop of “data - algorithm - scenario” to promote the continuous implementation of the business in multiple scenarios.
In line with improved performance and business expansion, Yidu Technology has further conveyed value signals through continuous repurchases, and also highlighted the growth resilience of medical technology companies in the Hong Kong stock capital repurchase wave. On December 12, Yidu Technology closed up more than 3%, and its stock price was HK$5.11.